NewslettersHepatic Cell NewsChimeric HDAC and the Cytoskeleton Inhibitor Broxbam as a Novel Therapeutic Strategy for Liver CancerBy Britya Ghosh - April 29, 20220316The potential suitability of broxbam for the treatment of liver cancer was investigated.[International Journal of Oncology]Abstract